Good insights.
You miss the multiplier benefit of scale here. Even for FY21 you can see the reduced accounting $rev from SaaS benefiting EBITDA . NXL have increased EBITDA guidance based on this.
Nuix catalysts going forward, page-61
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NXL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.56 |
Change
0.210(3.31%) |
Mkt cap ! $2.155B | |||
| Open | High | Low | Value | Volume |
| $6.40 | $6.63 | $6.31 | $11.04M | 1.701M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2500 | $6.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.58 | 7126 | 1 |
View Market Depth
| Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
| NXL (ASX) Chart |